Characteristics of asbestos concentration in lung as compared to asbestos concentration in various levels of lymph nodes that collect drainage from the lung

Ultrastructural Pathology

Volumn 31, Issue 2, 2007, Pages 95-133

  Dodson, Ronald F ^a   Shepherd, Sara ^b   Levin, Jeffrey ^b   Hammar, Samuel P ^c  

^a Dodson Environmental Consulting Inc   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^c Diagnostic Specialties Laboratory Inc   (United States)

Author keywords

Analytical electron microscopy; Asbestos; Lung; Lymph nodes

Indexed keywords

AMPHIBOLE; ASBESTOS;

ADULT; AGED; ANATOMY; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHATIC SYSTEM; MALE; MICROSCOPY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THORACIC CAVITY; TRANSMISSION ELECTRON MICROSCOPY;

AGED; AGED, 80 AND OVER; ASBESTOS; ASBESTOSIS; BODY BURDEN; HUMANS; INHALATION EXPOSURE; LUNG; LYMPH NODES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MINERAL FIBERS; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; THORAX;

EID: 34447117028     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120701423907     Document Type: Article

References (40)

1. Snipes MB. Long-term retention and clearance of particulates inhaled by mammalian species. Crit Rev Toxicol. 1989;20:175-211.
2. Gross P, Detreville RT. The lung as an embattled domain against inanimate pollutants: A precis of mechanisms. Am Rev Respir Dis. 1972;106:684-691.
3. Camner P. Alveolar clearance. Eur J Respir Dis Suppl. 1980;107:59-72.
4. Lauweryns JM, Baert JH. Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir Dis. 1977;115:625-683.
5. Lauweryns JM. The juxta-alveolar lymphatics in the human adult lung: Histological studies in 15 cases of drowning. Am Rev Respir Dis. 1970;102:877-885.
6. Leak LV. Lymphatic removal of fluids and particles in mammalian lung. Environ Health Perspect. 1980;35:55-76.
7. Kaltreider HB. Normal immune response. In: Crystal RG, West JB, eds. The Lung - Scientific Foundations. New York: Raven Press; 1991:499-510.
8. Netter FH. Respiratory system. In: Divertie MB, Brass A, eds. The Ciba Collection of Medical Illustrations. New Jersey: Ciba Pharmaceutical; 1979:32-33.
9. Hammar SP. Common neoplasms. In: Dail DH, Hammar SP, eds. Pulmonary Pathology. New York: Springer-Verlag; 1994:1123-1278.
10. Lippman M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles. Br J Ind Med. 1980;37:337-362.
11. Ferin J. Lung clearance of particulates. In: Aharonson CF, Ben-David A, Klingberg MA, eds. Air Pollution and the Lung. New York: Wiley; 1976:64-78.
12. Agarwal DK, Dogra RK, Shanker R. Pathobiochemical response of tracheobronchial lymph nodes following intratracheal instillation of polyvinylchloride dust in rats. Arch Toxicol. 1991;65:510-517.
13. Adamson IYR, Hedgecock C. Patterns of particle deposition and retention after instillation to mouse lung during acute injury and fibrotic repair. Exp Lung Res. 1995;21:695-709.
14. Lee KP, Kelly DP. The pulmonary response and clearance of Ludox colloidal silica after a 4-week inhalation exposure in rats. Fundam Appl Toxicol. 1992;19:399-410.
15. Absher MP, Hemenway DR, Leslie KO, Trombley L, Vacek P. Intrator-acid distribution and transport of aerosolized silica in the rat. Exp Lung Res. 1992;18:743-757.
16. Tosi P, Franzinelli A, Miracco C, et al. Silicotic lymph node lesions in non-occupationally exposed lung carcinoma patients. Eur J Respir Dis. 1986;68:362-369.
17. Craighead JE, Kleinerman J, Abraham JL, et al. Diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med. 1988;112:673-720.
18. Lee KP, Barras CE, Griffith FD, Waritz RS. Pulmonary response and transmigration of inorganic fibers by inhalation exposure. Am J Pathol. 1981;102:314-323.
19. Kanazawa K, Birbeck MS, Carter RL, Roe FJ. Migration of asbestos fibres from subcutaneous injection sites in mice. Br J Cancer. 1970;24:96-106.
20. Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes and pleural plaques from former shipyard workers. Am Rev Respir Dis. 1990;142:843-847.
21. Dodson RF, Huang J, Bruce JR. Asbestos content in the lymph nodes of nonoccupationally exposed individuals. Am J Ind Med. 2000;37:169-174.
22. Godwin MC, Jagatic J. Asbestos and mesothelioma. Env Res. 1970;3:391-416.
23. Auerbach O, Conston AS, Garfinkel L, Parks VR, Kaslow HD, Hammond EC. Presence of asbestos bodies in organs other than the lung. Chest. 1980;77:133-137.
24. Roggli VL, Benning TL. Asbestos bodies in pulmonary hilar lymph nodes. Mod Path. 1990;3:513-517.
25. Ferin J, Feldstein ML. Pulmonary clearance and hilar lymph node content in rats after particle exposure. Environ Res. 1978;16:342-352.
26. Williams MG, Dodson RF, Corn C, Hurst GA. A procedure for the isolation of amosite asbestos and ferruginous bodies from lung tissue and sputum. J Toxicol Environ Health. 1982;10:627-638.
27. Jaffe MS. Handling and washing fragile replicas. J Appl Phys. 1948;19:1187.
28. Dodson RF. Analysis and relevance of asbestos burden in tissue. In: Dodson RF, Hammar SP, eds. Asbestos: Risk Assessment, Epidemiology, and Health Effects. New York: Taylor & Francis; 2006:39-90.
29. Stanton MF, Layard M, Tegeris A, et al. Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst. 1981;67:965-975.
30. Tweedale G, McCulloch J. Chrysophiles versus chrysophobes: The white asbestos controversy, 1950s-2004. Isis. 2004;95:239-259.
31. Craighead JE, Mossman BT. The pathogenesis of asbestos-associated diseases. N Engl J Med. 1982;306:1446-1455.
32. Dodson RF, O'Sullivan M, Corn CJ, McLarty JW, Hammar SP. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Ultrastruct Pathol. 1997;21:321-336.
33. Dodson RF, Graef R, Shepherd S, O'Sullivan M, Levin J. Asbestos burden in cases of mesothelioma from individuals from various regions of the United States. Ultrastruct Pathol. 2005;29:415-433.
34. Langer AM, Selikoff IJ, Sastre A. Chrysotile asbestos in the lungs of persons in New York City. Arch Environ Health. 1971;22:348-361.
35. Rood AP, Streeter RR. Size distributions of occupational airborne asbestos textile fibres as determined by transmission electron microscopy. Ann Occup Hyg. 1984;28:333-339.
36. Sebastien P, Janson X, Gaudichet A, Hirsch A, Bignon J. Asbestos retention in human respiratory tissues: Comparative measurements in lung parenchyma and in parietal pleura. In: Wagner JC, ed. Biological Effects of Mineral Fibers. Lyon: IARC; 1980:237-246.
37. Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health. 2001;39:150-160.
38. Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann NY Acad Sci. 2002;982:160-176.
39. Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: Pathological evidence. Int J Hyg Environ Health. 2005;208:201-210.
40. Upton AC, Barrett JC, Becklake MR, et al. Health Effects Institute-Asbestos Research: Asbestos in public and commercial buildings: A literature review and synthesis of current knowledge. [Anonymous] Cambridge, MA: Health Effect Institute; 1991: P. 4-20, section 4.4.2.4.